Literature DB >> 16783583

Osteonecrosis of the hip after short courses of oral and inhaled steroids in a child with an increased number of glucocorticoid receptors.

Ilenia Drigo1, Alessia Saccari, Egidio Barbi, Fiora Bartoli, Giuliana Decorti, Alessandro Ventura.   

Abstract

We report an unusual case of osteonecrosis of the femoral head associated with recurrent myopathy and bone abnormalities in a two-year-old girl, in whom symptoms occurred after a ten-day course of oral betamethasone for infectious wheezy bronchitis, and eventually recurred and were worsened by topical treatment; a hypersensitivity to glucocorticoids is hypothesised.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783583     DOI: 10.1007/s00431-006-0197-x

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Bilateral femoral avascular necrosis in a man with psoriasis: responsibility of topical corticosteroids and role of cyclosporine.

Authors:  S Reichert-Pénétrat; P Tréchot; A Barbaud; P Gillet; J L Schmutz
Journal:  Dermatology       Date:  2001       Impact factor: 5.366

2.  Normocortisolemic Cushing's syndrome initially presenting with increased glucocorticoid receptor numbers.

Authors:  R S Newfield; G Kalaitzoglou; T Licholai; D Chilton; J Ashraf; E B Thompson; M I New
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

Review 3.  Glucocorticoid resistance and hypersensitivity.

Authors:  Carl D Malchoff; Diana M Malchoff
Journal:  Endocrinol Metab Clin North Am       Date:  2005-06       Impact factor: 4.741

4.  Osteonecrosis of the hip (Legg-Calvé-Perthes disease) in human immunodeficiency virus-infected children.

Authors:  Denise M Gaughan; Lynne M Mofenson; Michael D Hughes; George R Seage; Gregory L Ciupak; James M Oleske
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124

5.  Effect of glucocorticoid therapy on glucocorticoid receptors in children with autoimmune diseases.

Authors:  J Andreae; R Tripmacher; R Weltrich; W Rohde; R Keitzer; U Wahn; K Paul; F Buttgereit
Journal:  Pediatr Res       Date:  2001-01       Impact factor: 3.756

6.  A patient with hypocortisolism and Cushing's syndrome-like manifestations: cortisol hyperreactive syndrome.

Authors:  S Iida; Y Nakamura; H Fujii; J Nishimura; M Tsugawa; M Gomi; J Fukata; S Tarui; K Moriwaki; T Kitani
Journal:  J Clin Endocrinol Metab       Date:  1990-03       Impact factor: 5.958

7.  Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance.

Authors:  M Ruiz; U Lind; M Gåfvels; G Eggertsen; J Carlstedt-Duke; L Nilsson; M Holtmann; P Stierna; A C Wikström; S Werner
Journal:  Clin Endocrinol (Oxf)       Date:  2001-09       Impact factor: 3.478

8.  Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial.

Authors:  Péter Csonka; Minna Kaila; Pekka Laippala; Marja Iso-Mustajärvi; Timo Vesikari; Per Ashorn
Journal:  J Pediatr       Date:  2003-12       Impact factor: 4.406

9.  Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial.

Authors:  Abraham Oommen; Paul C Lambert; Jonathan Grigg
Journal:  Lancet       Date:  2003-11-01       Impact factor: 79.321

  9 in total
  3 in total

Review 1.  Steroid induced osteonecrosis: An analysis of steroid dosing risk.

Authors:  Christian Powell; Christopher Chang; Stanley M Naguwa; Gurtej Cheema; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2010-07-09       Impact factor: 9.754

2.  Inhaled corticosteroids and bone health.

Authors:  Carolyn Chee; Luckni Sellahewa; Joseph M Pappachan
Journal:  Open Respir Med J       Date:  2014-01-31

3.  Osteonecrosis of the Femoral Head in an Adolescent on Long-Term Inhalational Corticosteroids.

Authors:  Anthony C Egger; R Tracy Ballock
Journal:  Case Rep Pediatr       Date:  2017-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.